Internal Medicine, Endocrinology, Diabetes, & Metabolism · Worcester, MA
NPI
1023017373
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
55 Lake Ave N
Worcester, MA, 01655
Phone (508) 856-3206
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
483 services
Medicare patients, 2024
253
Average age 71
Drug cost, 2024
$2.6M
4,884 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard A Haas was code 99214 (office e&m - established), 265 times for 188 patients. In total Richard A Haas billed 483 services in 9 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 265 | 188 | $69.47 | $18K |
| 95251 Test - Miscellaneous | Facility | 109 | 69 | $26.53 | $2,892 |
| 99213 Office E&M - Established | Facility | 51 | 48 | $49.64 | $2,532 |
| 99204 Office E&M - New | Facility | 23 | 23 | $98.44 | $2,264 |
| 99215 Office E&M - Established | Facility | 17 | 15 | $113.72 | $1,933 |
By year: 2022 $31K for 487 services; 2023 $30K for 493 services; 2024 $30K for 483 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard A Haas prescribed most often to Medicare patients was Ozempic (Semaglutide), with 599 prescriptions and refills. In total Richard A Haas wrote 4,884 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 599 | 754 | 114 | $696K |
| Jardiance Empagliflozin | 393 | 764 | 100 | $427K |
| Trulicity Dulaglutide | 304 | 363 | 59 | $351K |
| Metformin Hcl Er Metformin Hcl | 242 | 624 | 84 | $3,699 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 195 | 370 | 66 | $32K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 194 | 492 | 79 | $20K |
| Atorvastatin Calcium Generic | 187 | 515 | 57 | $2,985 |
| Metformin Hcl Generic | 182 | 499 | 60 | $2,084 |
| Mounjaro Tirzepatide | 144 | 165 | 29 | $168K |
| Levothyroxine Sodium Generic | 108 | 294 | 30 | $1,412 |
| Lisinopril Generic | 107 | 318 | 40 | $1,110 |
| Tresiba Flextouch U-200 Insulin Degludec | 106 | 197 | 28 | $165K |
| Januvia Sitagliptin Phosphate | 104 | 205 | 29 | $109K |
| Glipizide Er Glipizide | 98 | 254 | 31 | $1,243 |
| Humalog Kwikpen U-100 Insulin Lispro | 83 | 139 | 24 | $21K |
Brand drugs: 2,773 claims; generic drugs: 1,633 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Richard A Haas were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.